In 2021, David Sabatini was a star. The molecular biologist, long associated with the Whitehead Institute and MIT, had helped map the mTOR pathway, central to how cells regulate growth, metabolism, and cancer. His lab was large, well-funded, and influential. Within scientific circles he was sometimes discussed as a potential Nobel contender. Then a younger colleague, Kristin Knouse, accused him of sexual harassment after what both parties described as a sexual relationship. An internal investigation by the Whitehead Institute found he had violated policies by failing to disclose the relationship and by fostering a "sexualised undercurrent" in his lab. He was forced out of Whitehead, lost his HHMI position, resigned his MIT professorship, and watched biotech affiliations and opportunities evaporate. He later described losing weight, hair, and his sense of a future. "I lost everything," he told Free Press reporter Suzy Weiss in 2022. "My whole life imploded."
The institutional process moved fast. Whitehead's outside investigation concluded he had broken rules governing relationships with people over whom he held career influence. MIT's own review reached similar conclusions about the undisclosed relationship and his failure to step back from mentoring roles. Protests and public pressure followed; a potential move to NYU's medical school collapsed amid student and faculty opposition. Sabatini became, in the language of the moment, radioactive.
He sued. In 2021 he filed defamation and related claims against Knouse, the Whitehead Institute, and its director Ruth Lehmann, arguing the investigation was a "sham," the relationship was consensual, and Knouse had acted to destroy him after he became involved with someone else. Knouse countersued, alleging sexual harassment and retaliation. Over years of litigation the claims against the institute were narrowed or dismissed. What remained was a direct contest between Sabatini and Knouse that went to trial in Suffolk County Superior Court in Boston.
On October 16, 2026, a jury of seven women and six men awarded Sabatini $6 million plus interest. It found that Knouse had defamed him and tortiously interfered with his ability to work. It rejected her counterclaims of sexual harassment and retaliation. Sabatini's lawyer called it the restoration of his good name. Sabatini himself described the moment as surreal after five years of financial, emotional, and physical strain. Knouse's attorney, Ellen Zucker, said her client would appeal and framed the result as evidence that "society still has a difficult time believing women."
The verdict does not erase the earlier institutional findings. Those were employer investigations under workplace policies, not judicial determinations of the facts presented at trial. The civil case turned on what the jury credited about the relationship, the lab environment, and the consequences of Knouse's statements. Billionaire Bill Ackman, who has publicly defended Sabatini and supported his subsequent research efforts, used the outcome to call for institutional reconsideration. Whether any of that materialises remains open; the legal process is not finished while an appeal is pending, and universities have historically been slow to reverse earlier personnel decisions.
The story sits at the intersection of several unresolved tensions. Power imbalances in academic labs are real, and rules requiring disclosure of relationships between mentors and mentees exist for reasons. At the same time, the rapid professional destruction that can follow an allegation, before full adversarial testing of the claims, has costs that are also real. Sabatini's case became a prominent example of the latter for critics of #MeToo institutional processes and, for others, a reminder that civil verdicts and workplace findings can diverge. The scientific work he led remains part of the literature; the personal and professional wreckage of 2021–2026 is now accompanied by a large damages award and a jury's rejection of the core harassment claim against him.
Whether this constitutes a full "rise" depends on what follows. An appeal could alter the outcome. Institutional reputations move slowly. What is clear from the public record is the sequence: a high-profile career ended by policy findings and public accusation, years of litigation, and a jury verdict that awarded millions and dismissed the counterclaims. The Free Press framed it as vindication after total collapse. The jury's decision supplies the legal basis for that framing; the earlier investigations and the pending appeal supply the continuing qualifications.
https://www.thefp.com/p/david-sabatini-lost-everything-then-he-won